1. Home
  2. WRN vs DNA Comparison

WRN vs DNA Comparison

Compare WRN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Copper and Gold Corporation

WRN

Western Copper and Gold Corporation

HOLD

Current Price

$2.15

Market Cap

609.2M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.34

Market Cap

599.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRN
DNA
Founded
2006
2008
Country
Canada
United States
Employees
N/A
485
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.2M
599.0M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
WRN
DNA
Price
$2.15
$9.34
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$4.58
$8.50
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$5.37
52 Week High
$4.26
$17.58

Technical Indicators

Market Signals
Indicator
WRN
DNA
Relative Strength Index (RSI) 37.08 50.73
Support Level $2.04 $7.59
Resistance Level $2.61 $10.05
Average True Range (ATR) 0.11 0.85
MACD 0.00 0.05
Stochastic Oscillator 17.50 41.87

Price Performance

Historical Comparison
WRN
DNA

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: